Activity of guanylyl cyclase activators on the reaction of tracheal smooth muscle contraction
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
Introduction: The subject of the study compare the influences of YC-1 guanylyl cyclase activator with ODQ guanylyl cyclase inhibitor on the tracheal smooth muscle contraction induced by carbachol. The study specified the influence of increasing concentrations of soluble guanylyl cyclase activators YC-1 and 8Br cGMP on the reaction of tracheal smooth muscle contraction released by carbachol. The author also examined the effect of increasing concentrations of soluble guanylyl cyclase inhibitor ODQ on the concentration-effect curves for carbachol. Material/Methods: Testing was conducted on an isolated trachea of both sexes of Wistar rats with weight ranging between 350 g and 450 g. Tracheas were prepared in accordance with the Akcasu (1959) method in Szadujkis-Szadurski (1996) modification. Concentration-effect curves were determined with the use of cumulated concentration method, in accordance with the van Rossum method (1963) in Kenakin (2006) modification. Results: According to conducted testing, activation of soluble guanylyl cyclase with the use of YC-1 and 8Br cGMP caused reduced reaction of the tracheal smooth muscle with carbachol on average to 80%. Comparing concentration-effect curves for carbachol before and after the use of 8Br cGMP, similar results were obtained for those released by YC-1. On the other hand, increasing concentrations of guanylyl cyclase inhibitor – ODQ cause shift of curves to the left, decrease of EC50 value and an increase of maximum reaction to carbachol. Conclusions: Carbachol, depending on concentration, causes tracheal smooth muscle contraction. According to testing, we can confirm that activation of guanylyl cyclase leads to reduction of the reaction of tracheal smooth muscle to carbachol on average up to 80%
Authors and Affiliations
Izabela Glaza, Leszek Szadujkis-Szadurski, Rafał Szadujkis-Szadurski, Marta Gajdus, Alicja Rzepka, Natalia Gurtowska
Yeast as a model for studying neurodegeneration
At the level of genetics and physiology the yeast Saccharomyces cerevisiae is are the best characterized eukaryotic cells. The yeast cells can be used as a model to study the mechanisms involved in human disease. Yeast...
Retigabine – a new antiepileptic drug with a different mechanism of action
Retigabine belongs to a new generation of antiepileptic drugs. Its mechanism of action is different from that previously known. Retigabine opens potassium channels of subfamily Kv 7, especially Kv 7.2 and Kv 7.3. The dru...
The mRNA expression levels of uncoupling proteins 1 and 2 in mononuclear cells from patients with metabolic disorders: obesity and type 2 diabetes mellitus
<b>Introduction:</b> Type 2 diabetes mellitus (T2DM) and obesity are metabolic disorders whose major hallmark is insulin resistance. Impaired mitochondrial activity, such as reduced ratio of energy production to respirat...
Antygeny układu grupowego Duffy: budowa, właściwości serologiczne i funkcja
Antygeny układu grupowego Duffy (Fy) są umiejscowione na glikoproteinie, która siedmiokrotnie przenika przez błonę komórkową i jest obecna na powierzchni krwinek czerwonych i komórek śródbłonka niektórych narządów. Białk...
Metabolizm hemu jako integralny element homeostazy żelaza
Hem jest kompleksem żelaza z protoporfiryną IX i pełni funkcję kofaktora w białkach hemowych biorących udział w licznych, istotnych dla komórki i dla całego organizmu procesach biologicznych. Dostarczenie odpowiedniej il...